The FDA approved omidubicel on December 8, 2025, the same day parent company Ayrmid announced positive results at the 2025 American Society of Hematology Annual Meeting. FDA approved omidubicel-onlv ...
National CPS data from 2012-2023 show declines in confirmed child maltreatment, but disparities remained, particularly among Black and female children. Confirmed child maltreatment declined, but ...
The CDC website now claims "studies supporting a link [between vaccines and autism] have been ignored by health authorities." A CDC webpage now states the claim “vaccines do not cause autism” is “not ...
FDA adds boxed warning to Elevidys and limits use to ambulatory DMD patients ≥4 years after reports of fatal acute liver failure in non-ambulatory patients. The FDA has approved revised labeling for ...
For over 100 years, type 1 diabetes (T1D) has traditionally been diagnosed and treated at the onset of symptomatic hyperglycemia, often accompanied by severe disease, including life-threatening ...
“This label expansion helps close a long-standing gap in the treatment of pediatric patients with hereditary antithrombin deficiency,” said George M. Rodgers, III, MD, PhD. FDA approved an expanded ...
"What is the possibility for your individual child that you're taking care of as a patient, as a family member advocate?" said Oliva Kim-McManus, MD. In this interview from the 2025 Child Neurology ...
Joshua Fitch is the senior editor for Contemporary Pediatrics. He joined the brand in March of 2023 as an editor before being promoted to senior editor in January 2024. Fitch graduated from Youngstown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback